American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. by Clark, M, Colombel, J, Feagan, B, Fedorak, R, Hanauer, S, Kamm, M, Mayer, L, Regueiro, C, Rutgeerts, P, Sandborn, W, Sands, B, Schreiber, S, Targan, S, Travis, S, Vermeire, S

“…The conference upon which this report is based was funded through an unrestricted educational grant from Abbott Laboratories. Abbott Laboratories representatives did not attend the conference, nor did they participate in any way in the development of this report.…”

Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen. by Aalamian, M, Tourkova, I, Chatta, G, Lilja, H, Huland, E, Huland, H, Shurin, G, Shurin, MR

“…The concentrations of PSA in cultures were determined by the AXSYM System (Abbott Laboratories, Wiesbaden, Germany). RESULTS: We noted that purified and LNCaP derived PSA inhibited the generation and maturation of DC (dendropoiesis) in vitro, which might have a crucial role in the induction and regulation of specific antitumor immune responses. …”

Pharmacokinetics and clinical effect of phenobarbital in children with severe falciparum malaria and convulsions. by Kokwaro, G, Ogutu, B, Muchohi, SN, Otieno, G, Newton, C

“…Plasma and cerebrospinal fluid (CSF) phenobarbital concentrations were measured with an Abbott TDx FLx fluorescence polarisation immunoassay analyser (Abbott Laboratories, Diagnostic Division, Abbott Park, IL, USA). …”

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART coh... by Walker, A, Ford, D, Gilks, C, Munderi, P, Ssali, F, Reid, A, Katabira, E, Grosskurth, H, Mugyenyi, P, Hakim, J, Darbyshire, J, Gibb, D, Babiker, A

“…FUNDING: UK Medical Research Council, the UK Department for International Development, the Rockefeller Foundation, GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim, and Abbott Laboratories.…”

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. by Mugyenyi, P, Walker, A, Hakim, J, Munderi, P, Gibb, D, Kityo, C, Reid, A, Grosskurth, H, Darbyshire, J, Ssali, F, Bray, D, Katabira, E, Babiker, A, Gilks, C, Grosskurth, H, Munderi, P, Kabuye, G, Nsibambi, D, Kasirye, R, Zalwango, E, Nakazibwe, M, Kikaire, B, Nassuna, G, Massa, R, Fadhiru, K

“…FUNDING: UK Medical Research Council, the UK Department for International Development, the Rockefeller Foundation, GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim, and Abbott Laboratories.…”

Developing routinely recorded clinical data from electronic patient records as a national resource to improve neonatal health care: the Medicines for Neonates research programme by Modi, N, Ashby, D, Battersby, C, Brocklehurst, P, Chivers, Z, Costeloe, K, Draper, E, Foster, V, Kemp, J, Majeed, A, Murray, J, Petrou, S, Rogers, K, Santhakumaran, S, Saxena, S, Statnikov, Y, Wong, H, Young, A

“…Unrestricted donations were supplied by Abbott Laboratories (Maidenhead, UK: £35,000), Nutricia Research Foundation (Schiphol, the Netherlands: £15,000), GE Healthcare (Amersham, UK: £1000). …”